Update on the major imported helminth infections in travelers and migrants.

Helminth infections cause considerable morbidity worldwide and may be frequently underdiagnosed especially in areas of lower endemicity. Patients may harbor latent infections that may become symptomatic years or decades after the initial exposure and timely diagnosis may be critical to prevent complications and improve outcomes. In this context, disease in special populations, such as immunosuppressed patients, may be of particular concern. Heightened awareness and recent diagnostic developments may contribute to the correct management of helminth infections in nonendemic regions. A review of the main helminth infections in travelers and migrants (strongyloidiasis, taeniasis-neurocysticercosis and schistosomiasis) is presented, focusing on epidemiology, developments in diagnosis, treatment and prevention.

[1]  T. Nutman,et al.  A novel, highly sensitive qPCR assay for the diagnosis of subarachnoid and ventricular neurocysticercosis and for assessing response to treatment. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  P. Chiodini,et al.  Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial. , 2019, The Lancet. Infectious diseases.

[3]  P. Rodari,et al.  High-dose or Multi-day Praziquantel for Imported Schistosomiasis? A Systematic Review. , 2019, Journal of travel medicine.

[4]  Z. Bisoffi,et al.  Morbidity Associated with Chronic Strongyloides stercoralis Infection: A Systematic Review and Meta-Analysis. , 2019, The American journal of tropical medicine and hygiene.

[5]  R. López-Vélez,et al.  Imported strongyloidiasis: Data from 1245 cases registered in the +REDIVI Spanish Collaborative Network (2009-2017) , 2019, PLoS neglected tropical diseases.

[6]  F. Gobbi,et al.  Restaging Pulmonary Schistosomiasis. , 2019, The American journal of tropical medicine and hygiene.

[7]  P. Hotez,et al.  Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women , 2019, PLoS neglected tropical diseases.

[8]  T. Nutman,et al.  Strongyloidiasis: A Neglected Tropical Disease. , 2019, Infectious disease clinics of North America.

[9]  E. F. Ruiz,et al.  Strongyloides stercoralis hyperinfection syndrome: a deeper understanding of a neglected disease , 2019, Journal of Parasitic Diseases.

[10]  G. Schwarzer,et al.  Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis. , 2019, The Lancet. Global health.

[11]  B. Fevang,et al.  Donor‐derived strongyloidiasis after organ transplantation in Norway , 2018, Transplant infectious disease : an official journal of the Transplantation Society.

[12]  A. Winkler,et al.  Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: eastern Europe , 2018, Parasites & Vectors.

[13]  A. White,et al.  Updates on the management of neurocysticercosis , 2018, Current opinion in infectious diseases.

[14]  J. Utzinger,et al.  Schistosomiasis , 2018, Nature Reviews Disease Primers.

[15]  H. Jäger,et al.  Active neurocysticercosis at the Hospital for Tropical Diseases, London: a clinical case series , 2018, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[16]  R. López-Vélez,et al.  Clinical Cysticercosis epidemiology in Spain based on the hospital discharge database: What's new? , 2018, PLoS neglected tropical diseases.

[17]  M. Díaz-Menéndez,et al.  Management of severe strongyloidiasis attended at reference centers in Spain , 2018, PLoS neglected tropical diseases.

[18]  J. Fillaux,et al.  Persistence of schistosomal transmission linked to the Cavu river in southern Corsica since 2013 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[19]  W. Hauser,et al.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  N. Suttorp,et al.  Schistosomiasis in European Travelers and Migrants: Analysis of 14 Years TropNet Surveillance Data. , 2017, The American journal of tropical medicine and hygiene.

[21]  A. Winkler,et al.  Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: Western Europe , 2017, Parasites & Vectors.

[22]  J. Keiser,et al.  Side Benefits of Mass Drug Administration for Lymphatic Filariasis on Strongyloides stercoralis Prevalence on Pemba Island, Tanzania. , 2017, The American journal of tropical medicine and hygiene.

[23]  T. Nutman,et al.  Molecular Diagnostics for Soil-Transmitted Helminths , 2016, The American journal of tropical medicine and hygiene.

[24]  J. H. Kim,et al.  Donor-Derived Strongyloidiasis Infection in Solid Organ Transplant Recipients: A Review and Pooled Analysis. , 2016, Transplantation proceedings.

[25]  D. Rollinson,et al.  Outbreak of urogenital schistosomiasis in Corsica (France): an epidemiological case study. , 2016, The Lancet. Infectious diseases.

[26]  Kavita Singh,et al.  Association Between Schistosoma haematobium Exposure and Human Immunodeficiency Virus Infection Among Females in Mozambique. , 2016, The American journal of tropical medicine and hygiene.

[27]  H. Nakajima,et al.  Albendazole and Corticosteroids for the Treatment of Solitary Cysticercus Granuloma: A Network Meta-analysis , 2016, PLoS neglected tropical diseases.

[28]  J. McCarthy,et al.  Application of a Multiplex Quantitative PCR to Assess Prevalence and Intensity Of Intestinal Parasite Infections in a Controlled Clinical Trial , 2016, PLoS neglected tropical diseases.

[29]  Z. Bisoffi,et al.  Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador , 2015, PLoS neglected tropical diseases.

[30]  David Bruce Conn,et al.  Importation and Transmission of Parasitic and Other Infectious Diseases Associated with International Adoptees and Refugees Immigrating into the United States of America , 2015, BioMed research international.

[31]  Mirko S. Winkler,et al.  Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis. , 2015, The Lancet. Infectious diseases.

[32]  L. van Lieshout,et al.  Clinical consequences of new diagnostic tools for intestinal parasites. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[33]  R. López-Vélez,et al.  Parasitic infections in travelers and immigrants: part I protozoa. , 2015, Future microbiology.

[34]  R. López-Vélez,et al.  Parasitic infections in travelers and immigrants: part II helminths and ectoparasites. , 2015, Future microbiology.

[35]  J. Zwang,et al.  Clinical Efficacy and Tolerability of Praziquantel for Intestinal and Urinary Schistosomiasis—A Meta-analysis of Comparative and Non-comparative Clinical Trials , 2014, PLoS neglected tropical diseases.

[36]  J. Lambertucci.  Revisiting the concept of hepatosplenic schistosomiasis and its challenges using traditional and new tools. , 2014, Revista da Sociedade Brasileira de Medicina Tropical.

[37]  F. Bruschi,et al.  Neurocysticercosis in Europe: Still a public health concern not only for imported cases. , 2013, Acta tropica.

[38]  M. van Esbroeck,et al.  A Schistosoma haematobium-Specific Real-Time PCR for Diagnosis of Urogenital Schistosomiasis in Serum Samples of International Travelers and Migrants , 2013, PLoS neglected tropical diseases.

[39]  P. Vounatsou,et al.  Strongyloides stercoralis: Global Distribution and Risk Factors , 2013, PLoS neglected tropical diseases.

[40]  M. Cetron,et al.  Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997-2009, part 2: migrants resettled internationally and evaluated for specific health concerns. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  Mary E. Wilson,et al.  GeoSentinel Surveillance of Illness in Returned Travelers, 2007–2011 , 2013, Annals of Internal Medicine.

[42]  J. Utzinger,et al.  Accuracy of Urine Circulating Cathodic Antigen Test for the Diagnosis of Schistosoma mansoni in Preschool-Aged Children before and after Treatment , 2013, PLoS neglected tropical diseases.

[43]  J. López-Abán,et al.  Systematic Review and Meta-Analysis of Artemisinin Based Therapies for the Treatment and Prevention of Schistosomiasis , 2012, PloS one.

[44]  A. van Gompel,et al.  Schistosomiasis in travellers and migrants. , 2011, Travel medicine and infectious disease.

[45]  E. Klement,et al.  Efficacy of praziquantel during the incubation and invasive phase of Schistosoma haematobium schistosomiasis in 18 travelers. , 2006, The American journal of tropical medicine and hygiene.